BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan Z, Zhou L, Hetherington CJ, Zhang DE. Hepatocytes contribute to soluble CD14 production, and CD14 expression is differentially regulated in hepatocytes and monocytes. J Biol Chem. 2000;275:36430-36435. [PMID: 10960472 DOI: 10.1074/jbc.M003192200] [Cited by in Crossref: 59] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Fernández-Real JM, Pérez del Pulgar S, Luche E, Moreno-Navarrete JM, Waget A, Serino M, Sorianello E, Sánchez-Pla A, Pontaque FC, Vendrell J, Chacón MR, Ricart W, Burcelin R, Zorzano A. CD14 modulates inflammation-driven insulin resistance. Diabetes 2011;60:2179-86. [PMID: 21700881 DOI: 10.2337/db10-1210] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 6.5] [Reference Citation Analysis]
2 Li SW, Gong JP, Wu CX, Shi YJ, Liu CA. Lipopolysaccharide induced synthesis of CD14 proteins and its gene expression in hepatocytes during endotoxemia. World J Gastroenterol 2002; 8(1): 124-127 [PMID: 11833086 DOI: 10.3748/wjg.v8.i1.124] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
3 Tahar R, Albergaria C, Zeghidour N, Ngane VF, Basco LK, Roussilhon C. Plasma levels of eight different mediators and their potential as biomarkers of various clinical malaria conditions in African children. Malar J 2016;15:337. [PMID: 27357958 DOI: 10.1186/s12936-016-1378-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
4 Reiner AP, Lange EM, Jenny NS, Chaves PH, Ellis J, Li J, Walston J, Lange LA, Cushman M, Tracy RP. Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults. Arterioscler Thromb Vasc Biol 2013;33:158-64. [PMID: 23162014 DOI: 10.1161/ATVBAHA.112.300421] [Cited by in Crossref: 83] [Cited by in F6Publishing: 57] [Article Influence: 9.2] [Reference Citation Analysis]
5 Chou MH, Chuang JH, Eng HL, Chen CM, Wang CH, Chen CL, Lin TM. Endotoxin and CD14 in the progression of biliary atresia. J Transl Med 2010;8:138. [PMID: 21172039 DOI: 10.1186/1479-5876-8-138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shitole SG, Biggs ML, Reiner AP, Mukamal KJ, Djoussé L, Ix JH, Barzilay JI, Tracy RP, Siscovick D, Kizer JR. Soluble CD14 and CD14 Variants, Other Inflammatory Markers, and Glucose Dysregulation in Older Adults: The Cardiovascular Health Study. Diabetes Care 2019;42:2075-82. [PMID: 31471378 DOI: 10.2337/dc19-0723] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Litzman J, Nechvatalova J, Xu J, Ticha O, Vlkova M, Hel Z. Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia. Clin Exp Immunol 2012;170:321-32. [PMID: 23121673 DOI: 10.1111/j.1365-2249.2012.04655.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
8 Lambrecht J, Tacke F. Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease. Front Immunol 2020;11:634409. [PMID: 33633748 DOI: 10.3389/fimmu.2020.634409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Mertens J, Bregadze R, Mansur A, Askar E, Bickeböller H, Ramadori G, Mihm S. Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity. J Mol Med (Berl) 2009;87:815-24. [PMID: 19468702 DOI: 10.1007/s00109-009-0479-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
10 Soltani N, Marandi SM, Kazemi M, Esmaeil N. The Exercise Training Modulatory Effects on the Obesity-Induced Immunometabolic Dysfunctions. Diabetes Metab Syndr Obes 2020;13:785-810. [PMID: 32256095 DOI: 10.2147/DMSO.S234992] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
11 Fomin ME, Tai LK, Bárcena A, Muench MO. Coexpression of CD14 and CD326 discriminate hepatic precursors in the human fetal liver. Stem Cells Dev 2011;20:1247-57. [PMID: 20964518 DOI: 10.1089/scd.2010.0218] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
12 Lufrano M, Jacob A, Zhou M, Wang P. Sphingosine kinase‑1 mediates endotoxemia‑induced hyperinflammation in aged animals. Mol Med Rep 2013;8:645-9. [PMID: 23817990 DOI: 10.3892/mmr.2013.1562] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hozumi H, Tada R, Murakami T, Adachi Y, Ohno N. Comparative analysis of hepatic CD14 expression between two different endotoxin shock model mice: relation between hepatic injury and CD14 expression. PLoS One 2013;8:e53692. [PMID: 23308276 DOI: 10.1371/journal.pone.0053692] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
14 van Montfoort N, van der Aa E, van den Bosch A, Brouwers H, Vanwolleghem T, Janssen HL, Javanbakht H, Buschow SI, Woltman AM. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism. J Virol. 2016;90:6187-6199. [PMID: 27099316 DOI: 10.1128/jvi.02903-15] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
15 Malone DF, Falconer K, Weiland O, Sandberg JK. The dynamic relationship between innate immune biomarkers and interferon-based treatment effects and outcome in hepatitis C virus infection is altered by telaprevir. PLoS One 2014;9:e105665. [PMID: 25166593 DOI: 10.1371/journal.pone.0105665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
16 Druszczynska M, Wlodarczyk M, Janiszewska-Drobinska B, Kielnierowski G, Zawadzka J, Kowalewicz-Kulbat M, Fol M, Szpakowski P, Rudnicka K, Chmiela M, Rudnicka W. Monocyte signal transduction receptors in active and latent tuberculosis. Clin Dev Immunol 2013;2013:851452. [PMID: 23401703 DOI: 10.1155/2013/851452] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
17 Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 2010; 16(11): 1321-1329 [PMID: 20238398 DOI: 10.3748/wjg.v16.i11.1321] [Cited by in CrossRef: 233] [Cited by in F6Publishing: 216] [Article Influence: 21.2] [Reference Citation Analysis]
18 Mueller JL, Feeney ER, Zheng H, Misdraji J, Kruger AJ, Alatrakchi N, King LY, Gelrud L, Corey KE, Chung RT. Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. Clin Transl Gastroenterol 2015;6:e114. [PMID: 26448455 DOI: 10.1038/ctg.2015.36] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
19 Rapsinski GJ, Newman TN, Oppong GO, van Putten JPM, Tükel Ç. CD14 protein acts as an adaptor molecule for the immune recognition of Salmonella curli fibers. J Biol Chem 2013;288:14178-88. [PMID: 23548899 DOI: 10.1074/jbc.M112.447060] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 4.1] [Reference Citation Analysis]
20 Kostadinova L, Shive CL, Anthony DD. Elevated Autotaxin and LPA Levels During Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation. Cancers (Basel) 2019;11:E1867. [PMID: 31769428 DOI: 10.3390/cancers11121867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
21 Cai C, Shi X, Korff S, Zhang J, Loughran PA, Ruan X, Zhang Y, Liu L, Billiar TR. CD14 contributes to warm hepatic ischemia-reperfusion injury in mice. Shock. 2013;40:115-121. [PMID: 23656919 DOI: 10.1097/SHK.0b013e318299d1a7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Shive CL, Judge CJ, Clagett B, Kalayjian RC, Osborn M, Sherman KE, Fichtenbaum C, Gandhi RT, Kang M, Popkin DL, Sieg SF, Lederman MM, Rodriguez B, Anthony DD. Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection. Vaccine 2018;36:453-60. [PMID: 29254840 DOI: 10.1016/j.vaccine.2017.12.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
23 Karhukorpi J, Yan Y, Niemela S, Valtonen J, Koistinen P, Joensuu T, Saikku P, Karttunen R. Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14. Clin Exp Immunol. 2002;128:326-332. [PMID: 11985523 DOI: 10.1046/j.1365-2249.2002.01837.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 2.8] [Reference Citation Analysis]
24 Zhou Z, Xu MJ, Gao B. Hepatocytes: a key cell type for innate immunity. Cell Mol Immunol. 2016;13:301-315. [PMID: 26685902 DOI: 10.1038/cmi.2015.97] [Cited by in Crossref: 135] [Cited by in F6Publishing: 129] [Article Influence: 22.5] [Reference Citation Analysis]
25 Chou MH, Chuang JH, Eng HL, Tsai PC, Hsieh CS, Liu HC, Wang CH, Lin CY, Lin TM. Effects of hepatocyte CD14 upregulation during cholestasis on endotoxin sensitivity. PLoS One 2012;7:e34903. [PMID: 22511970 DOI: 10.1371/journal.pone.0034903] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
26 Uehara A, Sugawara S, Watanabe K, Echigo S, Sato M, Yamaguchi T, Takada H. Constitutive expression of a bacterial pattern recognition receptor, CD14, in human salivary glands and secretion as a soluble form in saliva. Clin Diagn Lab Immunol 2003;10:286-92. [PMID: 12626456 DOI: 10.1128/cdli.10.2.286-292.2003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]